Where Is Margin Quietly Leaking in Healthtech and Digital Health?

In most healthtech companies, margin leaks in three predictable places: customer acquisition and sales cycles that run too long for the contract value, clinical and support operations that scale linearly with users instead of flattening, and cloud/data infrastructure costs that grow faster than revenue. Value Chain Analysis is the right tool to find these leaks because it forces you to attach cost and margin contribution to each activity — from lead generation through onboarding, clinical delivery, billing, and retention — rather than looking only at a blended P&L that hides where the money actually goes.

Why healthtech margin leaks are hard to see

Healthtech P&Ls are deceptive. A company can show strong gross margin at the software layer while bleeding contribution margin through activities that look "operational" rather than "cost of goods." A telehealth platform's clinician network, a remote-monitoring vendor's device logistics, a payer-facing analytics firm's implementation team — these sit in gray zones between COGS and OpEx, and they are exactly where margin disappears.

The regulatory and clinical dimension makes it worse. Compliance work (HIPAA, SOC 2, state licensure, FDA pathways for SaMD) is real, necessary cost that rarely gets attributed to specific products or customer segments. So you know it's expensive but not where it's expensive. Value Chain Analysis breaks the blended view apart and lets you ask a sharper question: which activities create value the customer pays for, and which are quietly subsidized by everything else?

Applying Value Chain Analysis to a digital health business

Michael Porter's Value Chain separates a business into primary activities (that touch the product and customer directly) and support activities (that enable the rest). Here's a concrete healthtech walkthrough.

Primary activities — map cost and margin to each:

1. Inbound / data acquisition — sourcing clinical data, integrations with EHRs, device ingestion. Ask: what does it cost to onboard a data source, and does that cost recur per customer or amortize across all of them? Good looks like: integration cost that drops sharply after the first few connections.

2. Operations / clinical delivery — the software plus any human-in-the-loop clinical work (nurse triage, physician review, care coordination). Ask: does delivery cost per patient/member fall as volume grows, or stay flat? Good looks like: automation absorbing volume so headcount grows sublinearly.

3. Outbound / product delivery — hosting, data pipelines, device shipping and returns. Ask: is your cloud bill growing faster than active users? Good looks like: infra cost per active user declining quarter over quarter.

4. Sales & marketing — enterprise/payer sales cycles, provider channel work, direct-to-consumer acquisition. Ask: what is fully loaded CAC by segment, and how does it compare to segment gross margin and contract length? Good looks like: payback periods that fit your cash runway, not aspirational LTV math.

5. Service / retention — implementation, customer success, support, renewals. Ask: how much implementation and support cost does a given contract consume in year one versus the revenue it generates? Good looks like: implementation cost recovered well before renewal.

Support activities — where hidden cost concentrates:

• Regulatory & security (compliance, audits, clinical governance) — allocate this to segments; enterprise/payer deals often carry far more of it than SMB or consumer.
• Technology development — R&D split between building new value versus maintaining integrations and technical debt.
• HR & clinical staffing — recruiting and credentialing licensed providers is a real, recurring cost in care-delivery models.
• Procurement — cloud contracts, third-party data licenses, device suppliers.

The exercise that matters: put a dollar figure and a margin-contribution estimate on each activity, by customer segment. The leaks announce themselves — usually an activity that consumes disproportionate cost for the revenue it supports, or one that refuses to scale.

Turning the analysis into an execution plan

Finding the leak is half the job. The other half is deciding what to do: renegotiate a cloud contract, productize an integration so it stops eating engineering time, shift a customer segment to self-serve onboarding, or exit a segment whose compliance load erases its margin. Each move needs a financial case the board will accept.

This is where a tool like Percision can compress the work. Full disclosure: I write for Percision, so weigh this accordingly. The platform runs your business context through structured reasoning steps and produces a Value Chain-style breakdown alongside financial intelligence — DCF valuation, 60+ ratios, and warning-sign flags — in minutes rather than weeks, and it exports to Excel with an audit trail so your finance team can pressure-test the numbers. It's positioned as a co-pilot: it drafts the analysis and the board deck; your leadership team makes the calls.

When Percision is genuinely the right fit: you need a defensible first-pass margin map fast, you're prepping a board or investor conversation, or your finance team is small and stretched. When it isn't: if you already have clean, activity-level cost data in your accounting system, a competent FP&A analyst with a spreadsheet may get you there without new tooling. And when the leak is deeply clinical or regulatory — say, a licensure-driven cost structure specific to your care model — a healthtech-specialized human consultant will bring judgment no platform replaces. AI is strong at structuring and speed; it's weakest exactly where your business is most idiosyncratic.

For context on the speed-versus-judgment tradeoff: a 2023 BCG field experiment with Boston Consulting Group consultants found that generative AI meaningfully improved output on well-structured tasks but could reduce accuracy on tasks requiring nuanced judgment outside the tool's strengths. Value Chain Analysis is well-structured; the clinical-cost judgment on top of it often isn't. Use the tool for the first, keep humans on the second.

FAQ

Which margin leak is most common in early-stage healthtech? Sales-and-service cost relative to contract value. Long enterprise/payer cycles and heavy implementation consume margin before revenue recurs. Map fully loaded CAC and year-one service cost by segment first.

How is Value Chain Analysis different from just reading our P&L? The P&L shows what you spend by category. Value Chain Analysis shows where in the flow of creating and delivering value the spend happens — and lets you attach it to customer segments, exposing subsidized activities a blended P&L hides.

Can we do this without new software? Yes, if you have clean activity-level cost data and analyst time. Tools help most when data is messy or the timeline is tight.

If you want a first-pass value-chain and margin map for your digital health business quickly, you can try Percision and keep your leadership team in control of every decision.